Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Jonathan de Courcy's publication output changed over time?
ScholarIQpublication output · 2016–2026
Output grew0% over the shown period — from 1 works in 2016 to 1 in 2026.
1
3
1
1
1
2
2
1
20162017201820202023202420252026
What are the most-cited papers on Jonathan de Courcy?
ScholarIQmost cited works
Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes
Peter Anderson, Victoria Higgins, Jonathan de Courcy, Katerina Doslikova, Victoria A. Davis, M Karavali, James Piercy
Current Medical Research and Opinion. 2023133 CitationsOPEN ACCESS
A burden of illness study for neuropathic pain in Europe
Jonathan de Courcy, Hiltrud Liedgens, M Obradović, Tim Holbrook, Rafal Jakubanis
ClinicoEconomics and Outcomes Research. 201676 CitationsOPEN ACCESS
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
Roger von Moos, Jean‐Jacques Body, A. Rider, Jonathan de Courcy, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati, Yi Qian
S2764562432. 201749 CitationsOPEN ACCESS
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B
Amit Chhabra, Dean Spurden, Patrick F. Fogarty, Bartholomew J. Tortella, E Rubinstein, Simon Harris, Andreas M. Pleil, Jennifer M. Mellor, Jonathan de Courcy, José Alvir
S118812467. 202043 CitationsOPEN ACCESS
Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR+/HER2– Advanced/Metastatic Breast Cancer
Robert Wood, Debanjali Mitra, Jonathan de Courcy, Shrividya Iyer
Clinical Therapeutics. 201732 Citations
Related on ScholarIQ
Adelphi Group (United Kingdom)
Institution
Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes
Paper
A burden of illness study for neuropathic pain in Europe
Paper
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
Paper
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B
Paper
Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR+/HER2– Advanced/Metastatic Breast Cancer
Paper